| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2011.37.0890 |
| P953 | full work available at URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.37.0890 |
| P698 | PubMed publication ID | 22162583 |
| P50 | author | Hui K Gan | Q91842524 |
| Gregory R. Pond | Q131468591 | ||
| P2093 | author name string | Benoit You | |
| Gregory Pond | |||
| Eric X. Chen | |||
| P2860 | cites work | Association of trial registration with the results and conclusions of published trials of new oncology drugs | Q24288921 |
| CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials | Q24614627 | ||
| The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials | Q28185637 | ||
| Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research | Q28285027 | ||
| Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis | Q28476002 | ||
| Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles | Q29618882 | ||
| Systematic review of the empirical evidence of study publication bias and outcome reporting bias | Q29619094 | ||
| Trial Registration at ClinicalTrials.gov between May and October 2005 | Q33230454 | ||
| Issues in the registration of clinical trials | Q33284869 | ||
| Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement | Q33993977 | ||
| Comparison of registered and published primary outcomes in randomized controlled trials | Q34019194 | ||
| Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes | Q34117393 | ||
| Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors | Q34389549 | ||
| The hidden research paper | Q34661896 | ||
| The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. | Q36212911 | ||
| Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study | Q36248519 | ||
| Standards of reporting of randomized controlled trials in general surgery: can we do better? | Q36632857 | ||
| Reporting in randomized clinical trials improved after adoption of the CONSORT statement | Q36732977 | ||
| The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews | Q37692721 | ||
| Factors associated with failure to publish large randomized trials presented at an oncology meeting | Q44014171 | ||
| Claims of equivalence in medical research: are they supported by the evidence? | Q45948545 | ||
| Quality of randomized controlled trials reporting in the treatment of sarcomas | Q53080606 | ||
| Is this clinical trial fully registered?--A statement from the International Committee of Medical Journal Editors | Q53272988 | ||
| Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors | Q55894706 | ||
| Planned Equivalence or Noninferiority Trials Versus Unplanned Noninferiority Claims: Are They Equal? | Q59647307 | ||
| Randomized clinical trial design for assessing noninferiority when superiority is expected | Q81523860 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 210-216 | |
| P577 | publication date | 2011-12-12 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Consistency in the analysis and reporting of primary end points in oncology randomized controlled trials from registration to publication: a systematic review | |
| Consistency in the Analysis and Reporting of Primary End Points in Oncology Randomized Controlled Trials From Registration to Publication: A Systematic Review | |||
| P478 | volume | 30 |
| Q41368858 | 'Spin' in published biomedical literature: A methodological systematic review |
| Q50081852 | A systematic review of comparisons between protocols or registrations and full reports in primary biomedical research |
| Q33864361 | A systematic review of the processes used to link clinical trial registrations to their published results |
| Q44617042 | Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer |
| Q38719795 | Characteristic Analysis of Complementary and Alternative Medicine in Randomized Controlled Trials of Oncology. |
| Q34775141 | ClinicalTrials.gov registration can supplement information in abstracts for systematic reviews: a comparison study |
| Q92018525 | Comparison of Clinical Trial Changes in Primary Outcome and Reported Intervention Effect Size Between Trial Registration and Publication |
| Q47094827 | Comparison of primary endpoints between publications, registries, and protocols of phase III cancer clinical trials. |
| Q27027065 | Comparison of registered and published outcomes in randomized controlled trials: a systematic review |
| Q43661770 | Comparison of registered and published primary outcomes in randomized controlled trials of gastroenterology and hepatology |
| Q92356783 | Do oncology researchers adhere to reproducible and transparent principles? A cross-sectional survey of published oncology literature |
| Q35060093 | Empirical evidence for outcome reporting bias in randomized clinical trials of acupuncture: comparison of registered records and subsequent publications |
| Q33751652 | Evidence of selective reporting bias in hematology journals: A systematic review |
| Q82918751 | Evolution of Clinical Trials Registries |
| Q33614639 | Guidance in author instructions of hematology and oncology journals: A cross sectional and longitudinal study |
| Q35214578 | Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†. |
| Q48107493 | II. Trial registration for anaesthesia studies |
| Q26995526 | Inadequate use and regulation of interventions against publication bias decreases their effectiveness: a systematic review |
| Q38065776 | Influence of statistician involvement on reporting of randomized clinical trials in medical oncology |
| Q88698789 | Meta-Research on Oncology Trials: A Toolkit for Researchers with Limited Resources |
| Q41503758 | Outcome switching in randomized controlled oncology trials reporting on surrogate endpoints: a cross-sectional analysis |
| Q64928193 | Peer reviewed evaluation of registered end-points of randomised trials (the PRE-REPORT study): protocol for a stepped-wedge, cluster-randomised trial. |
| Q50035929 | Primary outcome switching among drug trials with and without principal investigator financial ties to industry: a cross-sectional study |
| Q49900242 | Promoting public access to clinical trial protocols: challenges and recommendations |
| Q49773294 | Publication proportions for registered breast cancer trials: before and following the introduction of the ClinicalTrials.gov results database |
| Q89079557 | Quality of Reporting in Oncology Randomized Controlled Trials: From 2011 to 2015 |
| Q26823871 | Quality of Reporting of Modern Randomized Controlled Trials in Medical Oncology: A Systematic Review |
| Q38571344 | Randomized controlled trials and neuro-oncology: should alternative designs be considered? |
| Q86890849 | Registration Rates, Adequacy of Registration, and a Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials Published in Surgery Journals |
| Q57455980 | Registration of published randomized trials: a systematic review and meta-analysis |
| Q37177363 | Reporting quality of randomised controlled trial abstracts among high-impact general medical journals: a review and analysis |
| Q28710019 | SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials |
| Q93161539 | Selective reporting bias in randomised controlled trials from two network meta-analyses: comparison of clinical trial registrations and their respective publications |
| Q27316649 | Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations |
| Q37464629 | The quality of registration of clinical trials: still a problem |
| Q53662464 | The reporting of adverse events in oncology phase III trials: a comparison of the current status versus the expectations of the EORTC members |
| Q38126350 | Transparent Reporting of Trials Is Essential |
| Q50160426 | Trends in endpoint selection in clinical trials of advanced breast cancer |
| Q90458774 | Trial registration as a safeguard against outcome reporting bias and spin? A case study of randomized controlled trials of acupuncture |
| Q35673269 | Using ClinicalTrials.gov to supplement information in ophthalmology conference abstracts about trial outcomes: a comparison study |
Search more.